Abstract  by unknown
JACC Febroary1997 ABSTRACT’S-Poster 251A
m980143 Heart Rate Variability: Gender Effects over Nine
K. Umetani,D.H. Singer,R. McCrsty,M. Atkinson.University Illinois
Chicago, IL, USA, Alexian Brothers Medical CantaCElk Grove ViI., IL, USA,
Inatitute of HeadMath, Boulder Creek, CA, USA
Gender ia thoughtto influence HRV. However, gender effects on 24 hr
HRV overa broadage rangerequiresclarification.Todefinegendereffects,
we determined24 hr time domain HRV of 102 healthymale (M) and 132
female (F) aubjects,ages 9-99 years, usingfive standardHRV measurea;
SDNN, SDANN, SDNN index, rMSSD and PRR50, HRV was determinedin
two decade grouping.HRV of age matchedM and F was comparedusing
unpairedt test. Changes in HRV of M and F with aging were assessed
usingANOVA. Relationship betweenheart rate (HR) and HRV also were
assessed.
Age fvVFNoof HR) SDNN SDANN SDNN index rMSSD PRR50
(yrs) Subjects (bpm) (mssc) (msec) (msec) (msec) (%)
8-29 M 29 76+ 11 1S1 +35 161 + S4 65+ 18 54 k 17 26 k 13
F 26 84+ 8* 142+ 45* 129 + 45* 62+ 18* 38+ 1S” 15+ 11*
30-19 M 40 76 b 7 148&26 133*30 85& 14 34+ 13 13* 10
F56 78+ 7* 129+ 31* 114 + 31* 58+ 13” 31 + 10 10*7
5(?-69 M 21 78+ 11 117+28 103+26 47+ 18 25+ 10 6 + 7
F 21 72+ 9 126+30 115+30 50+ 12 25& 8 5*4
70-89 M 12 68+ 11 125+30 111 +27 46+ 12 26& 9 4*4
F 27 73+ 8 114+24 104+23 40+ 11 25A 9 5*5
lP <0.05 male vs female in same age range
The resultsshow: 1) HRV (all measures)of M < W yeara wee higher
thanthatof age matchedF.2) Genderdifference(SDNN index,r$JSSDand
pRR53) persistedat variabledegree until49 yeare.3) Genderdifferencesin
HRV (all meaaures)disappeared>50 years. 4) Age relateddeclinein HRV
waa steeper for M than for F. 5) HR of M -= 50 yeare was lowerthan that
of age matchedF. In conclusion:1) Genderdoes influenceHRV.2) Gender
dirlerenceainHRV are age related,disappearingby50 years3) HigherHRV
of M <50 yeara is associatedwith lowermean HR, a findingsuggestiveof
higherlevelsof parasympatheticactivityin M.
m980144 Heart Rate Variability: Aging Effecta over Nine
K. Umetani,D.H. Singer,R. McCraty,M. Atkinson.University Winoia
Chicago, IL, USA, Alexian Brothers Medical CenteL Elk Grove ViI., IL, USA,
Institute of HeartMath, Boulder Creek, CA, USA
Lowheartratevariability(HRV) isconsideredan independentmarkerof risk
ofmortality.However,normalagingalsomaylowerHRV,limitingclinicalutility.
Furlherclarificationof aging effectsis needed. We determined24 hr time
domainHRV of 234 healthyaubjacta(9-99 years, male/female102/132) by
decade,uaingSDNN, SDANN, SDNN index,rtW3SDandpRR50.HRVvalues
were mmparad usingANOVA. The reaultsahow: 1) HRV (all measures)
decreased with aging. 2) rMSSD and PRR50 decreased rapidlyuntil5th
decade, SDNN index decreased linearlyuntil9th decade and SDNN and
SDANN decreased vety graduallyuntil 9th decade. 3) Decrease in HRV
resultedin 18Y0(SDNN),10% (rMSSD) and 15Y0(PRR50) of subjacteover
age 80 fallingbelowpubliahedcut-offpointsforriskofmortality.Inconclusion:
1) HRV declineswithnormalagingat varyingratesand to a variousdegree
with the differentmeasures, probablyreflectingdifferencesin autonomic
machaniams.2) Normal aging may decrease HRV (SDNN index, rMSSD
andpRR50) belowlevelsassociatedwithriskof mortality.3) Differentcut-off
pointsfor HRV (SDNN index,rMSSD and PRR50) shouldbe consideredfor
the elderly.
AW Noof SDNN SDANN SDNNindex rMSSD pRR50
(yrs) Subjects (msec) (msac) (msec) (msec) (%)
S-19 27 176&36 156+35 80& 19 51& 16 24& 13
20-29 26 149+46 134*45 69& 22 43* 20 1s•13
30-39 33 146+ 31* 133+ 32* 84* 15* 3a* 12* 13* 9*
40-48 65 132& 30” 116+ 31* 60+ 13* 31* ll”t 10* 9*t
50-59 19 123+ 26* 107+ 26* 55+ 16* 27& IO*t 7 k 7“*
60--69 23 122& 32* 111* 30” 43k 14”~5 23& 7“t 4 i 5*t
70-78 20 125& 24” 114* 22* 44& 11*R$ 26& 9*t 5& 6*t
60-S9 19 109+ 26*W 109+ 24*t 40+ 12”~5 25+ IO*t 4 + 4*t
lP c 0.05vs9-18 yrs,‘P <0.05 VS20-29yrs,*P <0.05 V530-39yffi,5P <0.05 VS
40-49yrs
1980-145/Reproducibility OfHeattRateVariability Analysia
In Patienta With Long Standing Type I Diabetea
A. Burger, M, CharIamb,A. Hamer,L. Weinraugh,J. D’Elia. Deaconess
Hospital, Boston, MA, USA, Joslin Diabetes Centec Harvard Medice/
School, Boston, MA, USA
Heart tate variability (HRV) has been usedto non-invasivelyassesscardiac
autonomicfunction.Becausecardiacautonomictone ia dynamic,the repro-
ducibilityof HRV analysismustbe demonstratedbeforeany conclusioncan
be drawnaboutsignificantchangesin HRV afterany intervention.
In 23 patientswith longstandingType I diabetea, 24 hour ambulatory
recordingswere obtainadat 1, 3, 8, and 12 months.The Table showsthe
Pearsoncorrelationcoefficients(r values)for the HRV analysisin the time
andfrequencydomain.
1 month. 3 month 6 month 1 yesr
SD NN 0.870 0.s11 0.645 0.653
ASDNN5 0.605 0.954 0.953 0.939
SDANN5 0.555 0.73s 0.765 0.827
PNN50 0.420 0.985 0.987 0.606
RMSSDNN 0,891 0.941 0,916 0.625
TotalPower 0.757 0.7s0 0.767 0.470
Ultralow 0.737 0.754 0.727 0,625
Vsrylow 0,823 0,914 0,s41 0.829
Lowfreq. 0.627 0,932 0.793 0.817
Highfreq. 0.614 0.835 0.794 0.778
Conclusion: Time and frequencydomainanalyaisof HRV from 24 hour
ambulatoryrecordingsin patientswithtype I diabetesare reproducibleand
can be usedto determinethe effectsof therapyon cardiacautonomicfunc-
tion.
1980-146/Heart RateVariability in Poat-lnfarction Patienta
with Reduced Lefl Ventricular Ejection Fraction ia
independent of Age
M. Malik,A.J. Carom.St. Geoge’a Hospital Medical School, London,
Eng/and
Measuresof heart rate variability(HRV) are knownto declinewithincreas-
ing age both in healthysubjectsand differentgroupsof cardiac patients.
However,correlationof HRV withage has not been investigatedin cardiac
patientsproneto sympatheticoverdrive.Thereforein thisstudy,association
of24-hourtime-domainmeasuresof HRV withage was assessedinpatients
ofthe EMIATtrialwhichinvestigatedsurvivoffiof acute myocerdialinfarction
aged s 75 yearswithleftventricularejectionfraction(LVEF) s 40%. Base-
line24-hourHelter recordingwas availablein 843 patientswithouta history
of previousmyocardialinfarction(142 female, mean age 59.3 + 9.8 yeare,
range27–75 yeacs).Twotime-domainHRV measures,SDNN and RMSSD,
were computedfrom edited beatstreamfiles of each Helter recordingand
correlatedwithage ofthe patienta.
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WhileSDNN valuesrepresentingoverallHRV correlatedonlymildlywith
age (r= –0.118, p < 0.01), the RMSSD valuesrepresentingthe ehorlterm,
presumablyvagal componentsof HRV did not correlatewith age at all (r
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= –0.053, NS). These results suggest that in post-infarction patients with
reduced LVEF,heart rate variability is mainly determined by the sympathetic
overdrive caused by the loss of left ventricular performance which masks the
physiologic influence of age.
m980147 Anti-ischemicEfficacyof Beta-blockerainEffortAnainaPatientsisCorrelatedwithHeartRate. ....
VariabilityChangeAfter Therapy
T. Kaji, T. Kohya, F.Tomita, T. One, Y. Itoh, A, Kitabatake. Dept. of
Cardiovascular Medicine, Hokkaido University School of Medicine,
Sepporo, Japan
Although it is reported that reduced heart rate variability (HRV) predicts pca
prognosis in patients (pts) with coronary artery disease, Iittledata iaavailable
about the effects of antianginal drugs on HRV. The aim of this study is
to compare the effects of various antianginal drugs on autonomic nervous
activity in pts with effort angina (EA) using ambulatory ECG monitoring (AEM)
and analysie of HRV. Forty-four pts with EA (55 + 9 years) were allocated to
3 treatment groups: (isosorbide dinitrate: 18 pts, diltiazem or nifedipine: 12
pts, and propranolol or metoprolol: 14 pts). AEM was performed before and
after 2 week treatment.
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Resu/fs: Beta-bl~kers significantly decreased LF/HF and increased HF,
and the degree of increase in HF (AHF) was significantly correlated with
the reduction of ischemic attacks (Fig. 1). Also, beta-blockers abolished
the morning peak of ischemic attacks, which was significantly related to
suppression of LF/HF (Fig. 2). Nitrates and Ca-antagonists did not change
any HRV parameters. Conclusion: Not only suppressed sympathetic tone
but also augmented vagal tone may contribute to the antianginal effect of
beta-blockers.
H980148 Effects of Various Antianglnal Agents on HeartRate Variability in Patients with Silent Myocardial
Ischemia
B. Takase, H. Hikita, A. Uehata, T. Nagai, K. Isojima, A. Kurita,
H. Nakamura. SalfDefense Force CarrtralHospital, Tokyo,Japan, National
Defense Medical Co//ege, Saitanra, Japan
Heart rate variability indices (HRV) and silent myocardial ischemic episodes
(SMI) can be used fo{ prognostication of ischemic heart disease. To investi-
gate the comparative effects of nipredilol (NP), certeolol (CL), diltiezem (DL)
and bepridil (BP) on HRV and SMI, 59 patients (pts) with chronic stable
angina underwent exercise treadmill testing (ETT) and 24 h ambulatory ECG
monitoring (AECG) before (Pre) and after (Pst) medications; fl-adrenergic
blockers of NP (6 mg, ISA –) and CL (15 mg, ISA +) while calcium channel
blockers of DL (90 mg) and BP (150 mg). BP has an additional class l-like
antiarrhythmic action. All pts had SMI ? 1 (1 z- mm, 1 z rein, J 60 ms) in
AECG. A single blind, 2-week placebo-controlled design was utilized, and
pts were randomly allocated to each treatment arm; 16 pte (62 * 8 years) in
NP, 16 pts (61 * 8 years) in CL, 15 pts (56 *6) in DL and 12 pts (66 + 9
yeara) in BP. HRV from AECG included mean RR interval (RR, ins), SDANN
(ins), SD (ins), rMSSD (ins), pNN50 (%) and frequency analysis of heati rate
spectrum resulted in low (L, ms, 0.04-0.15 Hz) and high (H, ms, 0.15-0.40
Hz) frequency components. Results in table (Pre/Pst; SMI, rI/24 h, median;
others, mean; *, p <0.05 vs Pre).
EIT time(s) SMI RR SDANN SD rMSSD PNN50 L H
NP 394/429” 2/0’ S14/950” 119/123 42/49” 21/27* 4i7* 14/1s slln*
CL 4291459” 2/0” S15/S40” 117/ S1 43/40 23122
. . .
5/4 16/15 9/ 9
DL 397/425” 2/0” S79/929” 140/139 46/47 23/27 516 15/15 9/10
BP 4571527’ 2/0” S761964’ 140/133 49/50 24/30 5i7 16/16 91;;
All medications ameliorated ETT results and SMI and increased RR
in AECG, whereas only NP increased HRV. Conclusion: Effects on HRV
were different among antianginal agents even if anti-ischemic effects were
identical. This should be considered in clinical practice.
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D981 137 AutomaticandEfficientR-WaveandP-WaveDiscriminationin RightAtriumUsinga Two-state
HiddenMarkovModel
W. Sun 1,H. Theres2, W, Combs 1, E. Panken 1, P. Fotuhi2, K. Stang12,
G. Baumann2. 1Medtronic, hrc., A4inneapo/is,Minnesota, USA, 2 Cfrarfte
Hospital, Berlin, Germany
Background: The current technique used in implantable devices of adjusting
atrial refractoV and atrial sensitivifyto discriminate between far field R-waves
(FFRW) and P-waves is limited. Reliable detection or rejection of FFRW in
atrial electrograms would avoid some causes of inappropriate atrial sensing,
thus improving DDD sensing and atrial arrhythmia detection. In addition, de-
tection of FFRWSmay be used as a measure for AV conduction time in atriai
tracking modes and allow discrimination of supra-ventricular tachyarrhythmia
from ventricular tachyarrhythmia in ICD patients. Study Gee/: Evaluate anew
technique - two-state hidden Markov model for R- and P-wave discrimina-
tion in atrium. Methods: Atrial and ventricular unipolar electrograms were
collected from 25 patients undergoing pacemaker implant or replacement.
Approximately 5 minutes of intrinsic electrograms were recorded and poet-
analyzed. A new two-state hidden Markov model was developed specifically
for FFRW and P-wave discrimination in the atrium. The recorded patients’
electrograms were analyzed using this model and the sensitivity and poaitive
predictivity of FFRW detection were evaluated. The collected atrial electm-
grams were visually examined and marked as the control for verification of
the detection analysis. Hesulta: FFRW detection using this model had an
overall sensitivity of 94.2 (4c 9.4)~o and a positive predictivity of 96.3 (~
4.4)%. While FFRWrejection using the same model had a sensitivity of 96.8
(4z3.8)% and a positive predictivelyof 99.1 (* 1.7)%. Conclusions: FFRW
and P-wave discrimination in right atrium by the two-state Hidden Markov
model is reliable and accurate, and can significantly improve atrial arrhythmia
management for pacemaker patients.
1981-1381 PredictionofAtrialFibri!lationl%llOVifing
PacemakerImplantation:Useof the
ElectrophysiologicalEvaluation
Y. Inoue, O. Igawa, A. Tomokuni, M. Sawaguchi, T. Suga, M. Adachi,
J. Miake, S. Fujita, 1.Hisadome, C. Shigemasa. Tottori Univereiiy Yonago,
Japan
Previous studies have concluded that non-physiological pacing (VW) more
often promotes the development of atrial fibrillation (AF) than does physio-
logical pacing (AA1/DDD).However, it remains unclear whether the electro-
physiological (EP) parameters offer any additional predictive value. Methods:
Thirly-eight patients (19 males and 19 females, mean age 68 t 11(mean +C
S.D.) years) with sick sinus syndrome (SSS) complicated with the paroxys-
mal atrial fibrillation (AF) were studied. We evaluated their atrial vulnerability
by the EP examination. We defined that if the patients had repetitive atrial
firing (RAF) or fractionated atrial activation (FAA) in the EP examination, their
atrial vulnerability was positive (VULP), and if they had not both response,
their atrial vulnerability was negative (VULn). After the EP evaluation, 11
patients were treated with VW pacing and 27 were treated with DDD/AAl.
None of the patients received any class I or Ill antiarrhythmic drugs. Re-
suks: The mean follow-up period was 2.9 + 1.8 years. Overall, AF was
documented in 17 patients (45%). The lowest incidence of AF was found
in the VULn patients with DDD/AAl (19% vs. 64Y0, O.R. 7.6, p c 0.01).
Considering other predictive factors (age, heart failure, structural heart dis-
ease), the EP evaluation was the most important predictor for the recurrence
of AF in the patients with DDD/AAl (sensitivity 70Y0and specificity 77%.
